Literature DB >> 18799558

Five-year risk of colorectal neoplasia after negative screening colonoscopy.

Thomas F Imperiale1, Elizabeth A Glowinski, Ching Lin-Cooper, Gregory N Larkin, James D Rogge, David F Ransohoff.   

Abstract

BACKGROUND: The appropriate interval for endoscopic rescreening after a negative colonoscopic examination is uncertain.
METHODS: We identified persons with no adenomas on baseline screening colonoscopy who returned at 5 years for follow-up colonoscopy. Findings were categorized according to the most advanced lesion present: no polyp, a hyperplastic polyp, a tubular adenoma less than 1 cm in diameter, an advanced adenoma (a tubular adenoma > or = 1 cm in diameter or a polyp with villous histologic features or high-grade dysplasia), or a cancer.
RESULTS: Baseline screening colonoscopy had identified 2436 persons with no adenomas; 1256 of them (51.6%) were rescreened a mean (+/-SD) of 5.34+/-1.34 years later. The mean age of this group at baseline was 56.7 years; 56.7% of its members were men. No cancers were found on rescreening (95% confidence interval [CI] for the detection rate, 0 to 0.24%). One or more adenomas were found in 201 persons (16.0%). A total of 19 advanced adenomas, of which 10 (52.6%) were distal to the splenic flexure, were found in 16 persons (1.3%). The risk of an advanced adenoma did not differ significantly between persons with no polyps at baseline and those with hyperplastic polyps at baseline (1.1% [12 of 1057] and 2.0% [4 of 199], respectively; P=0.30). Men were more likely than women to have any adenoma (tubular less than 1 cm in diameter or advanced) (relative risk, 1.88; 95% CI, 1.42 to 2.51) and to have an advanced adenoma (relative risk, 3.31; 95% CI, 1.02 to 10.8).
CONCLUSIONS: Among persons with no colorectal neoplasia on initial screening colonoscopy, the 5-year risk of colorectal cancer is extremely low. The risk of advanced adenoma is also low, although it is higher among men than among women. Our findings support a rescreening interval of 5 years or longer after a normal colonoscopic examination. 2008 Massachusetts Medical Society

Entities:  

Mesh:

Year:  2008        PMID: 18799558     DOI: 10.1056/NEJMoa0803597

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  68 in total

1.  Factors associated with adherence to the recommended postpolypectomy surveillance interval.

Authors:  Eun Ran Kim; Dong Hyun Sinn; Jin Yong Kim; Dong Kyung Chang; Poong-Lyul Rhee; Jae J Kim; Jong Chul Rhee; Young-Ho Kim
Journal:  Surg Endosc       Date:  2012-03-22       Impact factor: 4.584

2.  How should individuals with a false-positive fecal occult blood test for colorectal cancer be managed? A decision analysis.

Authors:  Ulrike Haug; Amy B Knudsen; Karen M Kuntz
Journal:  Int J Cancer       Date:  2012-03-29       Impact factor: 7.396

3.  An evidence-based microsimulation model for colorectal cancer: validation and application.

Authors:  Carolyn M Rutter; James E Savarino
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

4.  Multiple, zonal and multi-zone adenoma detection rates according to quality of cleansing during colonoscopy.

Authors:  Stefano Pontone; Cesare Hassan; Roberta Maselli; Paolo Pontone; Rita Angelini; Manuela Brighi; Gregorio Patrizi; Daniele Pironi; Fabio Massimo Magliocca; Angelo Filippini
Journal:  United European Gastroenterol J       Date:  2016-07-07       Impact factor: 4.623

5.  Colorectal cancer screening in elderly African-American patients.

Authors:  Shashideep Singhal; Siddharth Mathur; Kris Anand
Journal:  Dig Dis Sci       Date:  2010-01       Impact factor: 3.199

6.  Characterization of the pathologic and endoscopic measurements of colorectal polyp sizes with a focus on sessile serrated adenoma and high-grade dysplasia.

Authors:  Fan Li; Zheng Chen; Yu Yang; Xianghua Yi; Yunsheng Yang; Lanjing Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

7.  Risk of Metachronous Advanced Neoplasia in Patients With Multiple Diminutive Adenomas.

Authors:  Jung Yoon Kim; Tae Jun Kim; Sun-Young Baek; Soohyun Ahn; Eun Ran Kim; Sung Noh Hong; Dong Kyung Chang; Young-Ho Kim
Journal:  Am J Gastroenterol       Date:  2018-08-03       Impact factor: 10.864

8.  Quality indicators for colorectal cancer screening for colonoscopy.

Authors:  Philip S Schoenfeld; Jonathan Cohen
Journal:  Tech Gastrointest Endosc       Date:  2013-04

Review 9.  Interval cancers after colonoscopy-insights and recommendations.

Authors:  Silvia Sanduleanu; Ad M Masclee; Gerrit A Meijer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-08-21       Impact factor: 46.802

10.  Administrative Database Research Overestimates the Rate of Interval Colon Cancer.

Authors:  Jonathan Gotfried; Marc Bernstein; Adam C Ehrlich; Frank K Friedenberg
Journal:  J Clin Gastroenterol       Date:  2015-07       Impact factor: 3.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.